Linda Kokaine

Dr. Linda Kokaine

Department of Surgery, Riga Stradiņš University, Riga, Rīga, Latvia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
Stefano RossiStefano Rossi
Stefano Rossi
ASA Sgrò
A Sgrò
RBR Blanco-Colino
R Blanco-Colino
WAWur Ahmed
Wur Ahmed
NBN Brindl
N Brindl
EPE Pusey
E Pusey
Many surgeons routinely place intraperitoneal drains after elective colorectal surgery. However, enhanced recovery after surgery guidelines recommend against their routine use owing to a lack of clear clinical benefit. This study aimed to describe international variation in intraperitoneal drain placement and the safety of this practice. COMPASS (COMPlicAted intra-abdominal collectionS after colorectal Surgery) was a prospective, international, cohort study which enrolled consecutive adults undergoing elective colorectal surgery (February to March 2020). The primary outcome was the rate of intraperitoneal drain placement. Secondary outcomes included: rate and time to diagnosis of postoperative intraperitoneal collections; rate of surgical site infections (SSIs); time to discharge; and 30-day major postoperative complications (Clavien–Dindo grade at least III). After propensity score matching, multivariable logistic regression and Cox proportional hazards regression were used to estimate the independent association of the secondary outcomes with drain placement. Overall, 1805 patients from 22 countries were included (798 women, 44.2 per cent; median age 67.0 years). The drain insertion rate was 51.9 per cent (937 patients). After matching, drains were not associated with reduced rates (odds ratio (OR) 1.33, 95 per cent c.i. 0.79 to 2.23; P = 0.287) or earlier detection (hazard ratio (HR) 0.87, 0.33 to 2.31; P = 0.780) of collections. Although not associated with worse major postoperative complications (OR 1.09, 0.68 to 1.75; P = 0.709), drains were associated with delayed hospital discharge (HR 0.58, 0.52 to 0.66; P < 0.001) and an increased risk of SSIs (OR 2.47, 1.50 to 4.05; P < 0.001). Intraperitoneal drain placement after elective colorectal surgery is not associated with earlier detection of postoperative collections, but prolongs hospital stay and increases SSI risk.

30 September 2021 in Medicina
Verified
Journal Article
Open access
PDF file
LKLinda Kokaine
Linda Kokaine
AGAndris Gardovskis
Andris Gardovskis
Jānis GardovskisJānis Gardovskis
Jānis Gardovskis
The response to neoadjuvant chemoradiation therapy is an important prognostic factor for locally advanced rectal cancer. Although the majority of the patients after neoadjuvant therapy are referred to following surgery, the clinical data show that complete clinical or pathological response is found in a significant proportion of the patients. Diagnostic accuracy of confirming the complete response has a crucial role in further management of a rectal cancer patient. As the rate of clinical complete response, unfortunately, is not always consistent with pathological complete response, accurate diagnostic parameters and predictive markers of tumor response may help to guide more personalized treatment strategies and identify potential candidates for nonoperative management more safely. The management of complete response demands interdisciplinary collaboration including oncologists, radiotherapists, radiologists, pathologists, endoscopists and surgeons, because the absence of a multidisciplinary approach may compromise the oncological outcome. Prediction and improvement of rectal cancer response to neoadjuvant therapy is still an active and challenging field of further research. This literature review is summarizing the main, currently known clinical information about the complete response that could be useful in case if encountering such condition in rectal cancer patients after neoadjuvant chemoradiation therapy, using as a source PubMed publications from 2010–2021 matching the search terms “rectal cancer”, “neoadjuvant therapy” and “response”.

31 May 2024 in Experimental Oncology
Verified
Journal Article
Open access
PDF file
LKLinda Kokaine
Linda Kokaine
MRM. Radzina
M. Radzina
MLM. Liepa
M. Liepa
AGA. Gerina-Berzina
A. Gerina-Berzina
ESE. Sīviņa
E. Sīviņa
EME. Miklaševičs
E. Miklaševičs
Background. The non-operative management of rectal adenocarcinoma (RA) after neoadjuvant chemoradiation therapy (nCRT) has gained increasing attention. The “Watch and Wait” (“W&W”) strategy allows one to avoid surgery-related reduction in the quality of life due to permanent pelvic organ dysfunction or irreversible stoma. Still, the oncological safety of this strategy is under evaluation. Aim. To share a single-center experience of the “W&W” strategy. Materials and Methods. The retrospective analysis of 125 patients who received nCRT in 2016—2021 was performed. Patients who met the European Society for Medical Oncology (ESMO, 2017) criteria of clinical complete response (cCR) and received non-operative management were analyzed. Results. Ten patients (8%) were re-staged after nCRT as cCR and followed the “W&W” strategy. Patients’ characteristics: 7 female, 3 male; mean age 67.3 years. Tumor characteristics: pre-treatment N+ was present in 7 cases; G1 adenocarcinoma in a majority of cases; mean tumor distance from the anal verge — 5.85 cm; mean tumor circumference — 71%; mean tumor length — 3.87 cm. The mean follow-up time was 30 months. Local regrowth or/and distant metastases developed in 3 cases. The 2-year disease-free survival was 70%. Conclusions. Most of the patients following the “W&W” strategy have benefited. However, to reduce the number of relapses, it is necessary to perform a more careful selection of patients. Стан питання. Консервативне ведення хворих на аденокарциному прямої кишки після неоад'ювантної хіміопроменевої терапії привертає все більшу увагу клініцистів. Очікувальна стратегія дозволяє уникнути зниження якості життя внаслідок спричинених хірургічним втручанням порушень функцій органів малого тазу або незворотної стоми. Разом з тим, онкологічна безпека такої стратегії потребує подальших досліджень. Матеріали та методи. Проведено ретроспективний аналіз 125 хворих, які одержували неоад'ювантну хіміопроменеву терапію в 2016—2021 рр. Проаналізовано клінічні дані хворих, які задовольняли критеріям повної клінічної відповіді за настановами Європейського товариства медичної онкології (ESMO, 2017) та були проліковані консервативними методами. Результати. 10 хворих (8%) (7 жінок, 3 чоловіки, середній вік 67,3 роки) після неоад'ювантної хіміопроменевої терапії було переглянуто щодо стадії захворювання та визначено повну клінічну відповідь з наступним застосуванням очікувальної стратегії у подальшому веденні цих хворих. До лікування 7 хворих були охарактеризовані як N+. У більшості випадків у хворих було діагнозовано аденокарциному диференціювання G1; пухлина в середньому розташовувалась на відстані 5,85 см від краю анусу і займала в середньому 71% кола кишки; середня довжина пухлини була 3,87 см. Середній час подальшого спостереження за хворими склав 30 місяців. Місцевий ріст пухлини та/або віддалені метастази визначено у трьох хворих. Дворічна виживаність без ознак хвороби склала 70%. Висновки. У більшості хворих очікувальна стратегія мала свої переваги. Однак для зменшення кількості рецидивів слід проводити більш ретельний відбір хворих, для яких буде застосовуватись такий підхід.

20 September 2019 in Medicina
Verified
Journal Article
Open access
PDF file
ZDZanda Daneberga
Zanda Daneberga
DBDace Bērziņa
Dace Bērziņa
VBViktors Borosenko
Viktors Borosenko
ZKZita Krumina
Zita Krumina
LKLinda Kokaine
Linda Kokaine
EMEdvins Miklasevics
Edvins Miklasevics
Background and objectives: Familial adenomatous polyposis is one of the APC-associated polyposis conditions described as genetically predetermined colorectal polyposis syndrome with a variety of symptoms. The purpose of this study was to determine sequence variants of the APC gene in patients with familial adenomatous polyposis (FAP) phenotype and positive or negative family history. Materials and Methods: Eight families with defined criteria of adenomatous polyposis underwent molecular genetic testing. Coding regions and flanking intron regions of the APC gene were analyzed by Sanger sequencing. Results: Eight allelic variants of the APC gene coding sequence were detected. All allelic variants of the APC gene were predicted to be pathogenic based on criteria according to the “Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology” (2015), four of them c.1586_1587insAT, c.2336delT, c.3066_3067insGA, and c.4303_4304insC, were considered novel. Conclusions: The timely molecular genetic analysis of APC germline variants and standardized interpretation of the pathogenicity of novel allelic variants has a high impact on choice for treatment, cancer prevention, and family genetic counseling.

1 August 2023 in Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.
Verified
Journal Article
Open access
PDF file
LKLinda Kokaine
Linda Kokaine
IBInese Briede
Inese Briede
ABAndrejs Brikuns
Andrejs Brikuns
AGAndris Gardovskis
Andris Gardovskis
JGJānis Gardovskis
Jānis Gardovskis
Burkitt lymphoma (BL) is a highly aggressive mature B-cell neoplasm with the highest incidence in a pediatric population. Three clinical subtypes of BL are known: sporadic, endemic, and immune deficiency associated. The most common site of involvement in the case of the sporadic form is an ileocecal region. We describe a rare case of sporadic BL in a 71-year-old male with a primary localisation in the rectum presenting with progressive bowel obstruction and rectal bleeding. The clinical evaluation involved colonoscopy, biopsy with a following morphological examination, computerised tomography of thorax, abdomen and pelvis, magnetic resonance imaging of pelvis, and laboratory analysis. Due to the unclear tumorous mass and progressive clinical symptoms, surgical treatment was applied – laparotomy, total mesorectal excision with the formation of permanent colostomy. Morphological examination of the specimen revealed a phenotype characteristic to BL. One month after the surgery, two single liver metastasis were detected. The patient received six courses of DA-EPOCH chemotherapy. Post-treatment radiological examinations revealed full clinical remission and disease-free survival for 68 months (5 years and 8 months).